Healthcare
Chinese medical device company Ankon raises $100m
Shanghai-based Ankon Medical Technologies, which develops medical equipment for gastric examination, has raised a $100 million round of funding from investors including SBCVC.
Hong Kong X invests six local start-ups
Hong Kong X-Tech Startup Platform, an angel fund and accelerator, has made its first investments by backing six local technology companies.
India's PE-backed Aster DM refiles for IPO
Indian hospital chain Aster DM Healthcare has refiled for an IPO in which its PE backer Olympus Capital Asia will make a partial exit.
Lilly Asia closes healthcare fund at $450m hard cap
China-focused Lilly Asia Ventures (LAV) has closed its fourth healthcare-focused fund at the hard cap of $450 million.
Qiming leads $20m round for China cancer specialist
Qiming Venture Partners has led a $20 million round for New Horizon Health, a Chinese start-up that develops cancer screening technology, with participation from existing investors Legend Capital and SBCVC.
Deal focus: VCs to rebalance Indian shortcoming
Lifestyle changes due to economic development in India are impacting the country's disease patterns. Fidelity International is bringing much needed venture capital to a medical research space addressing the issue
Temasek leads $57m round for China biotech firm
Singapore’s Temasek Holdings has led a $57 million Series B round for Chinese drug developer Hangzhou Just Biotherapeutics (Just China).
China’s Gu Sheng Tang raises $150m in equity, debt funding
Gu Sheng Tang, a traditional Chinese medicine (TCM) clinic chain, has raised RMB1.01 billion ($150 million) in a Series D round comprising RMB510 million in equity and RMB500 million in debt.
Eight Roads, F-Prime invest $25m in India's PlasmaGen
Indian biopharmaceuticals company PlasmaGen BioSciences has raised a $25 million funding round led by Eight Roads Ventures.
Indian healthcare services platform receives $15m Series C
Indian healthcare services platform operator 1mg Technologies has secured a $15 million Series C round led by HBM Healthcare Investments.
Creador buys minority stake in Indian hospital chain
Creador has paid INR2.75 billion ($42 million) for a minority stake in Paras Healthcare, which manages a chain of five hospitals in northern India.
C-Bridge closes second China healthcare fund at $400m
C-Bridge, a Chinese private equity firm that concentrates on late-stage growth capital and buyout opportunities in the healthcare space, has closed its second fund at the hard cap of $400 million.
KKR to invest $200m in Indian hospital operator
KKR has agreed to invest approximately $200 million for a 49% stake in India-based Radiant Life Care with a view to helping the specialty hospital operator expand its network of facilities nationwide.
Singapore's Spring Seeds to invest $73m in tech start-ups
Singapore-government backed Spring Seeds Capital has committed S$100 million ($73 million) to an investment program targeting domestic start-ups developing high-end technology.
Quadria invests Singapore, Vietnam hospitals
Healthcare-focused private equity firm Quadria Capital has acquired stakes in Singapore medical center operator MWH Holdings and Vietnam’s FV Hospital.
French VC joins $13m round for Japanese biopharma player
France-based venture capital firm Seventure Partners has joined a $13.1 million funding round for Japanese biopharmaceuticals development company Anaeropharma Science.
OrbiMed leads $30m round for China's Zai Lab
Zai Lab, a pharmaceutical company that licenses pre-clinical findings in the West for development into drugs in China, has received $30 million in Series C funding led by existing investor OrbiMed.
PE investors back $402m Sinovac take-private
A consortium of private equity investors has agreed to privatize US-listed Chinese biopharmaceutical player Sinovac Biotech in a deal worth $401.8 million, bringing a contentious bidding process to an end.
IFC invests $60m in Hong Kong's idsMED
The International Finance Corporation (IFC), the investment arm of the World Bank, has invested $60 million in Hong Kong-based medical supply chain solutions provider IDS Medical Systems Group (idsMED).
AGIC-led consortium buys US pharma player
AGIC Capital, a private equity firm established in 2015 to focus on China-Europe cross-border investments, has secured its first deal in the US with an agreement to acquire pharmaceutical manufacturer Ritedose Corporation.
EMIA invests Cambodia unit of iCare Benefits
Emerging Markets Investment Advisers (EMIA) has acquired a significant minority stake in the Cambodia division of iCare Benefits, a Singapore-based company that provides employers with worker benefit programs.
IFC set to back Morgan Stanley's $300m Thailand fund
The International Finance Corporation (IFC) is considering an investment of up to $25 million in a Thailand-focused fund launched by Morgan Stanley Private Equity Asia (MSPEA).
China’s BeauCare Clinics secures $29m Series B
BeauCare Clinics, a Chinese plastic surgery clinic chain, has raised RMB200 million ($29 million) in a Series B round of funding led by GP Capital.
PE-backed WuXi Biologics completes Hong Kong re-listing
WuXi Biologics, a Chinese contract R&D services provider to the global pharmaceutical industry that was taken private by a PE-backed consortium in late 2015, gained 38% on its Hong Kong trading debut following a HK$3.97 billion ($510 million) IPO.